Emergent Biosolutions
EBS
EBS
140 hedge funds and large institutions have $265M invested in Emergent Biosolutions in 2024 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 30 increasing their positions, 51 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% less funds holding
Funds holding: 141 → 140 (-1)
11% less call options, than puts
Call options by funds: $7.37M | Put options by funds: $8.31M
41% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 51
Holders
140
Holding in Top 10
2
Calls
$7.37M
Puts
$8.31M
Top Buyers
| 1 | +$16.3M | |
| 2 | +$14.3M | |
| 3 | +$9.3M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$7.11M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$3.68M |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$7.86M | |
| 3 | -$5.42M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$4.88M |
| 5 |
CCM
Carronade Capital Management
Darien,
Connecticut
|
-$3.75M |